For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Cancer immunotherapy: immune checkpoint pathway
Cancer immunotherapy research is trying to overcome the cancer’s ability to resist the immune responses and to stimulate the body's own mechanisms to remain effective against cancer.
Since 1990 there have been many strategies to block key immune checkpoint inhibitors and more than a dozen monoclonal antibodies are now used in cancer treatment.
Download a PDF of our Cancer immunotherapy: immune checkpoint pathway